» Articles » PMID: 37919320

Single-nucleus DNA Sequencing Reveals Hidden Somatic Loss-of-heterozygosity in Cerebral Cavernous Malformations

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Nov 3
PMID 37919320
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral Cavernous Malformations (CCMs) are vascular malformations of the central nervous system which can lead to moderate to severe neurological phenotypes in patients. A majority of CCM lesions are driven by a cancer-like three-hit mutational mechanism, including a somatic, activating mutation in the oncogene PIK3CA, as well as biallelic loss-of-function mutations in a CCM gene. However, standard sequencing approaches often fail to yield a full complement of pathogenic mutations in many CCMs. We suggest this reality reflects the limited sensitivity to identify low-frequency variants and the presence of mutations undetectable with bulk short-read sequencing. Here we report a single-nucleus DNA-sequencing approach that leverages the underlying biology of CCMs to identify lesions with somatic loss-of-heterozygosity, a class of such hidden mutations. We identify an alternative genetic mechanism for CCM pathogenesis and establish a method that can be repurposed to investigate the genetic underpinning of other disorders with multiple somatic mutations.

Citing Articles

Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.

DeBose-Scarlett E, Ressler A, Gallione C, Sapisochin Cantis G, Friday C, Weinsheimer S Am J Hum Genet. 2024; 111(10):2283-2298.

PMID: 39299239 PMC: 11480799. DOI: 10.1016/j.ajhg.2024.08.020.


Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).

Whitehead K, Toydemir D, Wooderchak-Donahue W, Oakley G, McRae B, Putnam A Int J Mol Sci. 2024; 25(14).

PMID: 39062925 PMC: 11276621. DOI: 10.3390/ijms25147682.

References
1.
Zhou Z, Tang A, Wong W, Bamezai S, Goddard L, Shenkar R . Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 2016; 532(7597):122-6. PMC: 4864035. DOI: 10.1038/nature17178. View

2.
Tomlinson I, Roylance R, Houlston R . Two hits revisited again. J Med Genet. 2001; 38(2):81-5. PMC: 1734812. DOI: 10.1136/jmg.38.2.81. View

3.
Boulday G, Rudini N, Maddaluno L, Blecon A, Arnould M, Gaudric A . Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med. 2011; 208(9):1835-47. PMC: 3171098. DOI: 10.1084/jem.20110571. View

4.
Gault J, Sain S, Hu L, Awad I . Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery. 2007; 59(6):1278-84. DOI: 10.1227/01.NEU.0000249188.38409.03. View

5.
Plummer N, Gallione C, Srinivasan S, Zawistowski J, Louis D, Marchuk D . Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol. 2004; 165(5):1509-18. PMC: 1618670. DOI: 10.1016/S0002-9440(10)63409-8. View